The L-C Ligament® is not available for sale in the EU or United States
Soft Tissue Regeneration is a medical device company dedicated to developing breakthrough technologies for regeneration of soft tissue. STR has developed the L-C Ligament®, a bioresorbable scaffold for the reconstruction of the anterior cruciate ligament (“ACL”) of the knee.
In the News
Robert Stanton, MD, past AOSSM President and Managing Partner of Orthopaedic Specialty Group, PC, Fairfield, CT, presented pre-clinical research on the L-C Ligament® at the annual meeting of the American Orthopaedic Society for Sports Medicine in Orlando, FL.
Learn more about the technologies we offer versus the current treatments for ACL Reconstruction Surgery, and our break through technology, the L-C Ligament®. Also see if you qualify for our European Clinical Trials.
CE Mark clinical trials set to start in Europe, 2nd Qtr. 2015.
First bioengineered ACL to completely regenerate.
Scientific Advisory Board
Our Advisory Board is comprised of world-renowned surgeons, professors and sports medicine experts.
Soft Tissue Regeneration wants to hear from you. Contact us to learn more.
If you are interested in learning more about Soft Tissue Regeneration join our mailing list for news and updates.